a d DCIS Hormone Therapy | Oncolink - Cancer Resources

DCIS Hormone Therapy

Ultima Vez Modificado: 19 de enero del 2007

Share article


Dear OncoLink "Ask The Experts,"

Has any new information come out at recent conferences about the addition of aromatase inhibitors after 2.5 yrs. of Tamoxifen for estrogen-positive DCIS, after a lumpectomy with clear margins? A consultation indicated that it was not necessary in my case. In my research, I find that 5 yrs. of Tamoxifen is considered adequate for DCIS.


Kevin R. Fox, MD, Assistant Director, Clinical Affairs and Associate Professor of Hematology/Oncology at the Abramson Cancer Center of the University of Pennsylvania, responds:

Your research is correct. The current standard for DCIS is tamoxifen for five years. There is no role for aromotase inhibitors in the treatment of DCIS at this time.

I Wish You Knew

Screening with Mammography: Looking at the Controversy

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información